These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. Thom MH; White PJ; Williams RM; Sturdee DW; Paterson ME; Wade-Evans T; Studd JW Lancet; 1979 Sep; 2(8140):455-7. PubMed ID: 89511 [TBL] [Abstract][Full Text] [Related]
3. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Beresford SA; Weiss NS; Voigt LF; McKnight B Lancet; 1997 Feb; 349(9050):458-61. PubMed ID: 9040575 [TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715 [TBL] [Abstract][Full Text] [Related]
5. The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens. Campbell S; McQueen J; Minardi J; Whitehead MI Postgrad Med J; 1978; 54 Suppl 2():59-64. PubMed ID: 740582 [TBL] [Abstract][Full Text] [Related]
6. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Beral V; Bull D; Reeves G; Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308 [TBL] [Abstract][Full Text] [Related]
9. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Key TJ; Pike MC Br J Cancer; 1988 Feb; 57(2):205-12. PubMed ID: 3358913 [TBL] [Abstract][Full Text] [Related]
10. Oestrogen-induced endometrial hyperplasia in gonadal dysgenesis. de Koos EB Proc R Soc Med; 1974 Jun; 67(7):590-1. PubMed ID: 4853428 [TBL] [Abstract][Full Text] [Related]
12. Oestrogen therapy and endometrial carcinoma. Studd JW; Thom M; Patterson M Lancet; 1979 Jun; 1(8128):1239. PubMed ID: 87699 [No Abstract] [Full Text] [Related]
13. Endolymphatic stromal myosis in two patients on progestagen therapy. Behary CM; Dollberg L; Czernobilsky B Contraception; 1976 Jan; 13(1):1-6. PubMed ID: 1245113 [No Abstract] [Full Text] [Related]
14. The role of hormones in the etiology and prevention of endometrial cancer. Gambrell RD Clin Obstet Gynaecol; 1986 Dec; 13(4):695-723. PubMed ID: 3791826 [TBL] [Abstract][Full Text] [Related]
15. [Hormone therapy and the risk of cancer in the climacteric]. Kuhl H; Taubert HD Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599 [No Abstract] [Full Text] [Related]
16. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations. Aylward M; Maddock J; Parker A; Protheroe DA; Ward A Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584 [TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and breast cancer. Gambrell RD Maturitas; 1987 Aug; 9(2):123-33. PubMed ID: 3309572 [TBL] [Abstract][Full Text] [Related]
19. Endometrial carcinogenesis and its relation to oestrogens. Fox H Pathol Res Pract; 1984 Sep; 179(1):13-9. PubMed ID: 6390390 [TBL] [Abstract][Full Text] [Related]
20. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]